
    
      Study Design:

        -  Multicenter

        -  Phase III

        -  Randomized

        -  Double Blind

        -  Prospective and Comparative

        -  Experiment duration: 105 days

        -  5 visits

        -  Efficacy

        -  Adverse event
    
  